Hodgkin lymphoma (HL) comprises two disease entities: nodular lymphocyte predominant
Hodgkin lymphoma (NLPHL) and classical Hodgkin lymphoma (cHL). The new WHO …

Purpose Lymphocyte-predominant Hodgkin's lymphoma (LPHL) is rare and differs in
histologic and clinical presentation from classical Hodgkin's lymphoma (cHL). To shed more …

Epstein–Barr virus (EBV) is associated with around one-third of Hodgkin's lymphoma (HL)
cases and this association is believed to be causal. In these EBV-associated cases, there is …

Pediatric Hodgkin lymphoma (HL) comprises approximately a fifth of all patients with HL in
India. Seventy-four cases of pediatric classical Hodgkin Lymphoma (cHL) from a regional …

Classical Hodgkin lymphoma (cHL) is a distinct clinical and pathological entity with
heterogeneous genetic and virological features, with regards to Epstein–Barr virus (EBV) …

In the WHO classification, the majority of Hodgkin-like ALCL cases as defined by the REAL
classification are considered to be CHL. However, establishing a histological diagnosis for …

Background: Classic Hodgkin lymphoma (CHL) and nodular lymphocyte predominant
Hodgkin lymphoma (NLPHL) are clinically distinct entities, with different prognostic and …

Abstract We analyzed Epstein-Barr virus association in classical Hodgkin's lymphoma from a
single center in Austria with special emphasis on the latent membrane protein1 gene …

Background The programmed death receptor (PD-1) and ligand (PD-L1) pathway act by
suppressing the antitumor response in chronic Hodgkin lymphoma (cHL). In this study, we …

Abstract Background Classical Hodgkin lymphoma (cHL) in children is often associated with
EBV infection, more commonly in developing countries. Procedure Here we describe the …